MIRUS BIO LLC (United States) holds 4 active US FDA Type II Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “MIRUS BIO LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/mirus-bio-llc

Overview

MIRUS BIO LLC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering REVIT GMP AAV ENHANCER; TRANSIT-VIRUSGEN GMP TRANSFECTION REAGENT.

API / Drug Master Files

MIRUS BIO LLC holds 4 active (4 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • TRANSIT® AAVIATOR GMP TRANSFECTION REAGENTActive2026-09-17
  • VIRUSGEN GMP LV ENHANCERActive2026-07-23
  • REVIT GMP AAV ENHANCERActive2024-12-17
  • TRANSIT-VIRUSGEN GMP TRANSFECTION REAGENTActive2024-12-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MIRUS BIO LLC in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this MIRUS BIO LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.